Innovative Clinical-based Technology in the Hands of the Pharmacist | FDS

Special Guest:Jason Ausili, Chief Clinical Officer at FDS. Jason Ausili, Pharm.D., is the Chief Clinical Officer at FDS, Inc., where he’s focused on delivering innovative clinical-based technology solutions that help mobilize pharmacists as care providers and practice at the top of their license. Jason received his Doctor of Pharmacy degree from Butler University in 2002 and has over 20 years of experience working in a variety of areas within the industry. He’s held a variety of roles across the spectrum of community pharmacy and throughout his career has stayed centered on his aim to expand the scope of pharmacy practice, improve healthcare quality performance, and ensure pharmacists receive equitable payment for clinical services and improving patient outcomes. Prior to coming to FDS in 2017, Jason spent the previous two years at the National Association of Chain Drug Stores, a non-profit trade association, as the Director of Pharmacy Affairs. He has served on a number of pharmacy industry work groups over the years and has been actively involved with various professional organizations.   Background: In August 2020, the U.S. Department of Health and Human Services (HHS), through the Assistant Secretary for Health, issued guidance under the Public Readiness and Emergency Preparedness Act (PREP Act) to expand access to safe and effective COVID-19 vaccines when they are made available. This guidance authorizes state-licensed pharmacists to order and administer, and state-licensed or registered pharmacy interns acting under the supervision of the qualified pharmacist to administer, COVID-19 vaccinations to persons ages 3 or older, subject to certain requirements. In addition, President Biden has clearly stated his intention to make vaccinations available in all pharmacies across the country and just this week the federal government stated it plans to ship Covid-19 vaccines to retail pharmacies starting February 11th.   Challenges: Billing for a medical benefit is a new phenomenon for many community pharmacists. How can they align and integrate their current pharmacy management systems with expanded medical billing requirements? How will pharmacy’s align with patient vaccination registries to ensure automated reporting to state registries for reportable vaccine events? Solutions:  Pharmacists need to operate at the top of their licenses. They need to be able to integrate vaccination clinical documentation into their existing patient profiles. And will need to also provide efficient patient scheduling and an optimal patient experience. About FDS, Inc.: FDS strengthens the health of pharmacies and their patients. We empower community pharmacies to build the clinically focused New Era Pharmacy, enabling their business to thrive now and successfully transition to a provider of community and population health through data insights, purpose-built technology solutions, and clinical services enablement. Read more about FDS at www.fdsrx.com. FDS recently merged with Amplicare, a leading business intelligence and decision-automation platform in the pharmacy and healthcare industry. Designed by pharmacists for pharmacists, the platform is engineered with a big data approach. Amplicare's proprietary technology collects, analyzes, and leverages consumer, patient, clinical, and industry-level informatics to empower providers to proactively take informed actions that improve patient care and clinical outcomes.  With thousands of pharmacy subscribers, Amplicare delivers an unrivaled platform that increases patient retention, improves performance measures, grows and diversifies revenue streams, and enables providers to communicate with their patients more easily than ever before. Read more about Amplicare at www.amplicare.com. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices